Affinity Asset Advisors »

Mersana Therapeutics shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Mersana Therapeutics (MRSN) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Mersana Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mersana Therapeutics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mersana Therapeutics by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.9M 100k 28.93

More positions owned by Affinity Asset Advisors

Spdr Series Trust State Street Spd Put Option (XBI)
Apogee Therapeutics (APGE)
Insmed Com Par $.01 (INSM)
Abivax Sa Sponsored Ads (ABVX)
Ishares Tr Ishares Biotech Call Option (IBB)
Ventyx Biosciences (VTYX)
Xenon Pharmaceuticals (XENE)
Praxis Precision Medicines I Com New (PRAX)
Cytokinetics Com New (CYTK)
Amgen (AMGN)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Select Sector Spdr Tr State Street Hea Call Option (XLV)
Roivant Sciences SHS (ROIV)

View all positions for Affinity Asset Advisors

Top funds holding Mersana Therapeutics

Nextech Invest
Alamea Verwaltungs GmbH
Bain Capital Life Sciences Investors
Vanguard Group
Rock Springs Capital Management
Acadian Asset Management
Affinity Asset Advisors
BlackRock
Millennium Management
Gabelli Funds
AQR Capital Management
Geode Capital Management
Two Sigma Advisers
Mackenzie Financial
Yakira Capital Management

View all funds holding Mersana Therapeutics